Invention Grant
- Patent Title: Compounds and methods for modulating FXR
- Patent Title (中): 用于调节FXR的化合物和方法
-
Application No.: US12600879Application Date: 2008-07-11
-
Publication No.: US08153624B2Publication Date: 2012-04-10
- Inventor: Michael James Genin , Francisco Javier Agejas-Chicharro , Ana Belen Bueno Melendo , Peter Rudolph Manninen , Alan M. Warshawsky
- Applicant: Michael James Genin , Francisco Javier Agejas-Chicharro , Ana Belen Bueno Melendo , Peter Rudolph Manninen , Alan M. Warshawsky
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent Elizabeth Dingess-Hammond
- International Application: PCT/US2008/069719 WO 20080711
- International Announcement: WO2009/012125 WO 20090122
- Main IPC: A61K31/55
- IPC: A61K31/55 ; C07D405/00
Abstract:
Compounds of formula (I): formula (I) wherein variables are as defined herein and their pharmaceutical compositions and methods of use are disclosed as useful for treating dyslipidemia and diseases related to dyslipidemia.
Public/Granted literature
- US20100152166A1 COMPOUNDS AND METHODS FOR MODULATING FXR Public/Granted day:2010-06-17
Information query
